Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors
Clinical trial NCT02665416 · COMPLETED
Trial details
- NCT number
- NCT02665416
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2019-10-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.